AbbVie Hopes to Maintain Humira Exclusivity Through Secondary Patents and Regulatory Barriers to Entry

Holman, CM

Holman, CM (reprint author), Univ Missouri, Kansas City Sch Law, Columbia, MO 65211 USA.

BIOTECHNOLOGY LAW REPORT, 2017; 36 (1): 9

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索